ArticleCell & bioscience2018

Ligase IV inhibitor SCR7 enhances gene editing directed by CRISPR-Cas9 and ssODN in human cancer cells.

Zheng Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.